Follow The Filings

DBVT Dbv Technologies

Health Care, filed as Dbv Technologies S A Sponsored (ADS), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

  • 1 Owner
  • Max 0.1%
  • $6.3M

Who owns this now

Largest portfolio weights among holders, up to 0.1% (Stanley Druckenmiller, Duquesne Family Office). Not free-float ownership.

  1. Stanley Druckenmiller 0.12%

Who owns DBVT

Sorted by value, long equity only, as of 2026 Q2.

History
Stanley Druckenmiller, Duquesne Family Office 0.12% Hold 383,363 $6.3M History

1 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by DBVT's executives, directors and 10% owners in the last 12 months, from their Form 4s

All DBVT insider trades
  • None no insider bought on the open market
  • $15.5M sold by 1 insider outside a trading plan
  • None no planned (10b5-1) sales
  1. Bpifrance Epic Insider, +4 joint filers
    Sale
    $15.5M 3,369,093 shares at $4.60 32% of stake
    Traded Dec 17–18 Filed Dec 19, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 4 sales to cover taxes and 3 stock grants.

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 8.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G — Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 5.02,9.01 Filing Doc
8-K 5.03,5.07,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
DEF 14A Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 5.02,9.01 Filing Doc
10-K/A Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
10-K Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G/A — Filing Doc

Source: SEC EDGAR submissions, updated 2 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $15.73M $4.15M $5.64M
Net income -$72.73M $113.92M -$146.95M
Net margin * -462.4% 2744.4% -2607.3%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $158.92M $44.39M $212.94M
Total non-current assets * $24.07M $21.27M $20.78M
Total assets $182.99M $65.66M $233.72M
Total current liabilities $37.34M $31.14M $58.02M
Total non-current liabilities $5.46M $7.14M $6.92M
Total equity $140.19M $27.39M $168.77M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$79.65M -$104.47M -$121.18M
Cash from investing -$0.808M -$0.757M -$1.37M
Cash from financing $6.77M $0.587M $276.18M
Net change in cash -$67.83M -$108.91M $161.71M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.